- Home
- TCTM vs BTAI Comparison
TCTM vs BTAI Comparison
Compare TCTM & BTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCTM
- BTAI
- Stock Information
- Founded
- TCTM 2002
- BTAI 2017
- Country
- TCTM China
- BTAI United States
- Employees
- TCTM N/A
- BTAI N/A
- Industry
- TCTM Other Consumer Services
- BTAI Biotechnology: Pharmaceutical Preparations
- Sector
- TCTM Real Estate
- BTAI Health Care
- Exchange
- TCTM Nasdaq
- BTAI Nasdaq
- Market Cap
- TCTM 8.1M
- BTAI 7.2M
- IPO Year
- TCTM 2014
- BTAI 2018
- Fundamental
- Price
- TCTM $0.46
- BTAI $1.99
- Analyst Decision
- TCTM
- BTAI Buy
- Analyst Count
- TCTM 0
- BTAI 5
- Target Price
- TCTM N/A
- BTAI $42.60
- AVG Volume (30 Days)
- TCTM 1.0M
- BTAI 1.2M
- Earning Date
- TCTM 01-01-0001
- BTAI 03-27-2025
- Dividend Yield
- TCTM N/A
- BTAI N/A
- EPS Growth
- TCTM N/A
- BTAI N/A
- EPS
- TCTM N/A
- BTAI N/A
- Revenue
- TCTM $190,004,403.00
- BTAI $2,266,000.00
- Revenue This Year
- TCTM $99.90
- BTAI $105.36
- Revenue Next Year
- TCTM N/A
- BTAI $46.93
- P/E Ratio
- TCTM N/A
- BTAI N/A
- Revenue Growth
- TCTM N/A
- BTAI 64.20
- 52 Week Low
- TCTM $0.18
- BTAI $1.72
- 52 Week High
- TCTM $2.80
- BTAI $49.58
- Technical
- Relative Strength Index (RSI)
- TCTM 59.52
- BTAI 39.93
- Support Level
- TCTM $0.30
- BTAI $1.76
- Resistance Level
- TCTM $0.59
- BTAI $2.11
- Average True Range (ATR)
- TCTM 0.07
- BTAI 0.28
- MACD
- TCTM 0.01
- BTAI 0.02
- Stochastic Oscillator
- TCTM 55.97
- BTAI 16.98
About TCTM Tarena International Inc.
TCTM Kids IT Education Inc engages in the provision of IT-focused education services in Mainland China. The company has a single reportable segment: IT-focused Supplementary STEM Education Services. It offers supplementary science, technology, engineering, and mathematics (STEM) education programs to young children aged between three and eighteen through online teaching models and instructors from online or offline learning centers. The company also operates an education platform that offers distance instruction, classroom-based learning, and online learning modules.
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.